The mechanism for MIAT to exert chemoresistance to cancer cells is that MIAT can recruit a transcription factor, TATA-box binding protein-associated Factor 1 (TAF1), in the promoter region of sterol regulatory element binding transcription factor 1 (SREBF1) and enhance the expression of SREBF1 [46]. The gene discussed is SREBF1; the disease is cancer.